SEC comment letter
Filing comparison
SEC staff questioned ARGENX SE's accounting for MD&A
Letter dated 2025-08-25; published on EDGAR 2026-07-10 — the SEC releases comment letters only after the review closes.
We note that you do not include discussion of any patent rights directed to efgartigimod on page 56. To the extent any patent rights that you own or license with respect to this program are material to your business, please revise future filings to include disclosure that describes such patents or patent applications on an individual or patent family basis, or otherwise advise. ITEM 5.A. Operating and Financial…
Evidence
- Cited sections
- Item 4.B Business Overview Intellectual Property, page 55
- Direction
- staff to company
- Letter dated
- 2025-08-25
- Published on edgar
- 2026-07-10
- Reviewing
- ARGENX SE Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-38097 Dear Karl Gubitz: We have reviewed your filing and have the following comments. P
- Source
- SEC staff comment letter (UPLOAD)
- Topics
- MD&A
- Why
- SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.